Albert Juan Ramon1, Yongyi Yang2, Miles N Wernick1, P Hendrik Pretorius3, Karen L Johnson3, Piotr J Slomka4, Michael A King3. 1. Medical Imaging Research Center, Illinois Institute of Technology, Chicago, IL, USA. 2. Medical Imaging Research Center, Illinois Institute of Technology, Chicago, IL, USA. yangyo@iit.edu. 3. Department of Radiology, University of Massachusetts Medical School, Worcester, MA, USA. 4. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Abstract
BACKGROUND: We previously optimized several reconstruction strategies in SPECT myocardial perfusion imaging (MPI) with low dose for perfusion-defect detection. Here we investigate whether reducing the administered activity can also maintain the diagnostic accuracy in evaluating cardiac function. METHODS: We quantified the myocardial motion in cardiac-gated stress 99m-Tc-sestamibi SPECT studies from 163 subjects acquired with full dose (29.8 ± 3.6 mCi), and evaluated the agreement of the obtained motion/thickening and ejection fraction (EF) measures at various reduced dose levels (uniform reduction or personalized dose) with that at full dose. We also quantified the detectability of abnormal motion via a receiver-operating characteristics (ROC) study. For reconstruction we considered both filtered backprojection (FBP) without correction for degradations, and iterative ordered-subsets expectation-maximization (OS-EM) with resolution, attenuation and scatter corrections. RESULTS: With dose level lowered to 25% of full dose, the obtained results on motion/thickening, EF and abnormal motion detection were statistically comparable to full dose in both reconstruction strategies, with Pearson's r > 0.9 for global motion measures between low dose and full dose. CONCLUSIONS: The administered activity could be reduced to 25% of full dose without degrading the function assessment performance. Low dose reconstruction optimized for perfusion-defect detection can be reasonable for function assessment in gated SPECT.
BACKGROUND: We previously optimized several reconstruction strategies in SPECT myocardial perfusion imaging (MPI) with low dose for perfusion-defect detection. Here we investigate whether reducing the administered activity can also maintain the diagnostic accuracy in evaluating cardiac function. METHODS: We quantified the myocardial motion in cardiac-gated stress 99m-Tc-sestamibi SPECT studies from 163 subjects acquired with full dose (29.8 ± 3.6 mCi), and evaluated the agreement of the obtained motion/thickening and ejection fraction (EF) measures at various reduced dose levels (uniform reduction or personalized dose) with that at full dose. We also quantified the detectability of abnormal motion via a receiver-operating characteristics (ROC) study. For reconstruction we considered both filtered backprojection (FBP) without correction for degradations, and iterative ordered-subsets expectation-maximization (OS-EM) with resolution, attenuation and scatter corrections. RESULTS: With dose level lowered to 25% of full dose, the obtained results on motion/thickening, EF and abnormal motion detection were statistically comparable to full dose in both reconstruction strategies, with Pearson's r > 0.9 for global motion measures between low dose and full dose. CONCLUSIONS: The administered activity could be reduced to 25% of full dose without degrading the function assessment performance. Low dose reconstruction optimized for perfusion-defect detection can be reasonable for function assessment in gated SPECT.
Authors: Manoj V Narayanan; Michael A King; P Hendrik Pretorius; Seth T Dahlberg; Frederick Spencer; Ellen Simon; Eric Ewald; Edward Healy; Kirk MacNaught; Jeffrey A Leppo Journal: J Nucl Med Date: 2003-11 Impact factor: 10.057
Authors: Jonathan P Piccini; John R Horton; Linda K Shaw; Sana M Al-Khatib; Kerry L Lee; Ami E Iskandrian; Salvador Borges-Neto Journal: Circ Cardiovasc Imaging Date: 2008-09-17 Impact factor: 7.792
Authors: Albert Juan Ramon; Yongyi Yang; P Hendrik Pretorius; Piotr J Slomka; Karen L Johnson; Michael A King; Miles N Wernick Journal: J Nucl Cardiol Date: 2017-05-23 Impact factor: 3.872
Authors: Albert Juan Ramon; Yongyi Yang; P Hendrik Pretorius; Karen L Johnson; Michael A King; Miles N Wernick Journal: IEEE Trans Med Imaging Date: 2020-03-10 Impact factor: 11.037